Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) FCF Payout Ratio (2020 - 2025)

Pharma-Bio Serv's FCF Payout Ratio history spans 6 years, with the latest figure at 5.62 for Q2 2025.

  • For Q2 2025, FCF Payout Ratio fell 128.81% year-over-year to 5.62; the TTM value through Oct 2025 reached 7.76, down 63.74%, while the annual FY2025 figure was 7.76, 227.48% down from the prior year.
  • FCF Payout Ratio reached 5.62 in Q2 2025 per PBSV's latest filing, down from 2.46 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 2.38 in Q1 2024 to a low of 6.87 in Q2 2023.
  • Average FCF Payout Ratio over 5 years is 3.3, with a median of 3.83 recorded in 2022.
  • Peak YoY movement for FCF Payout Ratio: crashed 164.21% in 2022, then surged 64.23% in 2024.
  • A 5-year view of FCF Payout Ratio shows it stood at 1.45 in 2021, then plummeted by 164.21% to 3.83 in 2022, then tumbled by 79.59% to 6.87 in 2023, then soared by 64.23% to 2.46 in 2024, then tumbled by 128.81% to 5.62 in 2025.
  • Per Business Quant, the three most recent readings for PBSV's FCF Payout Ratio are 5.62 (Q2 2025), 2.46 (Q2 2024), and 2.38 (Q1 2024).